comparemela.com

Latest Breaking News On - Ladenburg thalm sh - Page 14 : comparemela.com

Athenex (NASDAQ:ATNX) Cut to Neutral at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH lowered shares of Athenex (NASDAQ:ATNX – Get Rating) from a buy rating to a neutral rating in a research report report published on Tuesday, The Fly reports. Athenex Stock Performance Shares of ATNX stock opened at $1.39 on Tuesday. The company has a current ratio of 1.09, a quick ratio of 1.00 […]

LADENBURG THALM/SH SH Lowers Essential Properties Realty Trust (NYSE:EPRT) Price Target to $27 00

Essential Properties Realty Trust (NYSE:EPRT – Get Rating) had its price objective decreased by LADENBURG THALM/SH SH from $28.00 to $27.00 in a research note issued on Thursday, The Fly reports. The brokerage currently has a “buy” rating on the stock. LADENBURG THALM/SH SH’s price objective suggests a potential upside of 16.28% from the stock’s […]

LADENBURG THALM/SH SH Downgrades New York Mortgage Trust (NASDAQ:NYMT) to Neutral

LADENBURG THALM/SH SH downgraded shares of New York Mortgage Trust (NASDAQ:NYMT – Get Rating) from a buy rating to a neutral rating in a research note published on Friday, Marketbeat.com reports. They currently have $3.00 price target on the real estate investment trust’s stock. Other equities research analysts have also recently issued reports about the […]

LADENBURG THALM/SH SH Lowers United Therapeutics (NASDAQ:UTHR) Price Target to $285 00

United Therapeutics (NASDAQ:UTHR – Get Rating) had its price objective cut by LADENBURG THALM/SH SH from $295.00 to $285.00 in a research note released on Thursday, The Fly reports. Several other equities research analysts have also recently weighed in on UTHR. The Goldman Sachs Group started coverage on United Therapeutics in a research note on […]

Allarity Therapeutics (NASDAQ:ALLR) Coverage Initiated at LADENBURG THALM/SH SH

Research analysts at LADENBURG THALM/SH SH initiated coverage on shares of Allarity Therapeutics (NASDAQ:ALLR – Get Rating) in a report issued on Friday, The Fly reports. The brokerage set a “buy” rating on the stock. ALLR opened at $2.06 on Friday. Allarity Therapeutics has a twelve month low of $1.10 and a twelve month high […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.